• Consensus Rating: Hold
  • Consensus Price Target: $7.78
  • Forecasted Upside: 30.72%
  • Number of Analysts: 9
  • Breakdown:
  • 3 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$5.95
▼ -0.09 (-1.49%)

This chart shows the closing price for CLVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Clarivate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLVT

Analyst Price Target is $7.78
▲ +30.72% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Clarivate in the last 3 months. The average price target is $7.78, with a high forecast of $10.00 and a low forecast of $6.00. The average price target represents a 30.72% upside from the last price of $5.95.

This chart shows the closing price for CLVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 investment analysts is to hold stock in Clarivate. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
11/30/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
2/28/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
5/29/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
8/27/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
11/25/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
2/23/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
4/23/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
5/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/9/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$8.50 ➝ $7.50Low
2/28/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$9.00 ➝ $8.00Low
2/28/2024BarclaysLower TargetUnderweight ➝ Underweight$7.00 ➝ $6.00Low
2/28/2024Royal Bank of CanadaLower TargetSector Perform ➝ Sector Perform$10.00 ➝ $8.00Low
2/28/2024OppenheimerLower TargetOutperform ➝ Outperform$11.00 ➝ $10.00Low
1/8/2024OppenheimerBoost TargetOutperform ➝ Outperform$10.00 ➝ $11.00Low
12/15/2023Wells Fargo & CompanyReiterated RatingEqual Weight ➝ Underweight$8.00Low
10/16/2023Jefferies Financial GroupUpgradeHold ➝ Buy$10.00 ➝ $8.50Low
10/5/2023OppenheimerLower TargetOutperform ➝ Outperform$11.00 ➝ $10.00Low
9/26/2023CitigroupLower TargetNeutral ➝ Neutral$10.00 ➝ $8.00Low
9/8/2023BarclaysDowngradeEqual Weight ➝ Underweight$8.00 ➝ $7.00Low
8/25/2023Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$9.00 ➝ $8.00Low
8/7/2023Bank of AmericaDowngradeNeutral ➝ Underperform$10.00 ➝ $6.00Low
8/4/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$11.00 ➝ $9.00Low
8/4/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$12.00 ➝ $8.00Low
8/4/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$14.00 ➝ $9.00Low
8/4/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$11.00 ➝ $9.50Low
8/4/2023OppenheimerLower TargetOutperform ➝ Outperform$12.00 ➝ $11.00Low
8/4/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$15.00 ➝ $8.00Low
6/12/2023OppenheimerInitiated CoverageOutperform$11.00Low
4/17/2023Royal Bank of CanadaReiterated RatingOutperform$14.00Low
3/15/2023Bank of AmericaInitiated CoverageNeutral ➝ NeutralLow
3/10/2023Royal Bank of CanadaReiterated RatingOutperform$14.00N/A
3/2/2023Wells Fargo & CompanyBoost TargetOverweight$14.00 ➝ $15.00Low
3/2/2023Royal Bank of CanadaBoost TargetOutperform$12.00 ➝ $14.00Low
2/6/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$11.00 ➝ $12.00Low
1/4/2023Morgan StanleyLower TargetOverweight$13.00 ➝ $11.00Low
11/9/2022Wells Fargo & CompanyLower TargetOverweight$15.00 ➝ $14.00Low
11/9/2022The Goldman Sachs GroupLower TargetBuy$17.00 ➝ $14.50Low
11/9/2022Morgan StanleyLower TargetOverweight$14.00 ➝ $13.00Low
11/9/2022Royal Bank of CanadaLower TargetOutperform$13.00 ➝ $12.00Low
10/7/2022Wells Fargo & CompanyLower TargetOverweight$18.00 ➝ $15.00Low
9/28/2022Royal Bank of CanadaLower Target$16.00 ➝ $13.00Low
9/27/2022Morgan StanleyLower TargetOverweight$15.00 ➝ $14.00Low
9/13/2022Morgan StanleyLower TargetOverweight$16.00 ➝ $15.00Low
8/10/2022Morgan StanleyLower TargetOverweight$17.00 ➝ $16.00Low
7/12/2022Wells Fargo & CompanyInitiated CoverageOverweight$20.00Low
7/1/2022Royal Bank of CanadaLower TargetOutperform$23.00 ➝ $18.00Low
5/26/2022Morgan StanleyLower TargetOverweight$18.00 ➝ $17.00Low
4/19/2022The Goldman Sachs GroupLower TargetBuy$23.00 ➝ $20.00High
3/11/2022Morgan StanleyLower TargetOverweight$20.00 ➝ $19.00Medium
2/7/2022Morgan StanleyLower TargetOverweight$28.00 ➝ $20.00Medium
2/4/2022CitigroupDowngradeBuy ➝ Neutral$35.00 ➝ $16.00Low
2/3/2022BarclaysDowngradeOverweight ➝ Equal Weight$25.00 ➝ $16.00Low
1/18/2022BarclaysLower Target$30.00 ➝ $25.00High
12/21/2021CitigroupInitiated CoverageBuy$35.00Medium
12/13/2021The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$29.00High
12/2/2021Morgan StanleyBoost TargetOverweight$27.00 ➝ $28.00High
9/30/2021Morgan StanleyLower TargetOverweight$30.00 ➝ $28.00Low
8/16/2021Bank of AmericaInitiated CoverageBuy$28.00High
7/30/2021Morgan StanleyLower TargetOverweight$32.00 ➝ $30.00Low
5/18/2021Morgan StanleyBoost TargetOverweight$30.00 ➝ $32.00Medium
4/30/2021Morgan StanleyBoost TargetOverweight$28.00 ➝ $30.00High
4/30/2021B. RileyBoost TargetBuy$30.00 ➝ $33.00High
3/31/2021Jefferies Financial GroupInitiated CoverageBuy$30.00High
3/15/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$28.00High
3/11/2021CitigroupInitiated CoverageBuy$36.00Low
3/8/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$28.00Medium
3/4/2021Morgan StanleyLower TargetEqual Weight ➝ Overweight$30.00 ➝ $28.00N/A
2/26/2021Morgan StanleyLower TargetEqual Weight$30.00 ➝ $28.00High
(Data available from 5/23/2019 forward)

News Sentiment Rating

0.27 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/26/2023
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/25/2023
  • 9 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/25/2023
  • 9 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/24/2024
  • 20 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/23/2024
  • 11 very positive mentions
  • 32 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/24/2024
  • 8 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2024
  • 7 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
5/23/2024

Current Sentiment

  • 7 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Clarivate logo
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $5.95
Low: $5.91
High: $6.08

50 Day Range

MA: $6.96
Low: $5.94
High: $7.65

52 Week Range

Now: $5.95
Low: $5.84
High: $10.03

Volume

5,092,552 shs

Average Volume

4,271,547 shs

Market Capitalization

$3.98 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24

Frequently Asked Questions

What sell-side analysts currently cover shares of Clarivate?

The following Wall Street sell-side analysts have issued reports on Clarivate in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Jefferies Financial Group Inc., Morgan Stanley, Oppenheimer Holdings Inc., Royal Bank of Canada, The Goldman Sachs Group, Inc., and Wells Fargo & Company.
View the latest analyst ratings for CLVT.

What is the current price target for Clarivate?

9 Wall Street analysts have set twelve-month price targets for Clarivate in the last year. Their average twelve-month price target is $7.78, suggesting a possible upside of 30.7%. Oppenheimer Holdings Inc. has the highest price target set, predicting CLVT will reach $10.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $6.00 for Clarivate in the next year.
View the latest price targets for CLVT.

What is the current consensus analyst rating for Clarivate?

Clarivate currently has 3 sell ratings, 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CLVT, but not buy more shares or sell existing shares.
View the latest ratings for CLVT.

What other companies compete with Clarivate?

Other companies that are similar to Clarivate include Five9, Autohome, RingCentral, StoneCo and DXC Technology. Learn More about companies similar to Clarivate.

How do I contact Clarivate's investor relations team?

Clarivate's physical mailing address is 160 Blackfriars Road, London X0, SE1 8EZ. The company's listed phone number is 442074334000 and its investor relations email address is [email protected]. The official website for Clarivate is www.clarivate.com. Learn More about contacing Clarivate investor relations.